Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Endo International plc
  6. News
  7. Summary
    ENDP   IE00BJ3V9050

ENDO INTERNATIONAL PLC

(ENDP)
  Report
Delayed Nasdaq  -  05/20 04:00:00 pm EDT
0.4650 USD   -19.52%
05/09BMO Capital Lowers Price Target for Endo International to $2 From $4, Maintains Market Perform Rating
MT
05/09Barclays Trims Endo International's Price Target to $1 From $2, Maintains Underweight Rating
MT
05/06Piper Sandler Downgrades Endo International to Underweight From Neutral, Lowers PT to $1 From $3
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Barclays Adjusts Endo International's Price Target to $5 From $7, Keeps Equalweight Rating

12/16/2021 | 09:38am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2021
All news about ENDO INTERNATIONAL PLC
05/09BMO Capital Lowers Price Target for Endo International to $2 From $4, Maintains Market ..
MT
05/09Barclays Trims Endo International's Price Target to $1 From $2, Maintains Underweight R..
MT
05/06Piper Sandler Downgrades Endo International to Underweight From Neutral, Lowers PT to $..
MT
05/06Top Midday Decliners
MT
05/06Endo International Posts Lower Q1 Adjusted Earnings, Revenue; Issues Q2 Guidance; Share..
MT
05/06ENDO INTERNATIONAL PLC Management's Discussion and Analysis of Financial Condition and..
AQ
05/06Tranche Update on Endo International plc's Equity Buyback Plan announced on April 30, 2..
CI
05/06Wall Street Set for Downbeat Session; US Jobs Report Shows Strong Gain
MT
05/06Top Premarket Decliners
MT
05/06TRANSCRIPT : Endo International plc, Q1 2022 Earnings Call, May 06, 2022
CI
More news
Analyst Recommendations on ENDO INTERNATIONAL PLC
More recommendations
Financials (USD)
Sales 2022 2 321 M - -
Net income 2022 -269 M - -
Net Debt 2022 7 378 M - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 109 M 109 M -
EV / Sales 2022 3,23x
EV / Sales 2023 3,53x
Nbr of Employees 3 103
Free-Float 99,1%
Chart ENDO INTERNATIONAL PLC
Duration : Period :
Endo International plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ENDO INTERNATIONAL PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 5
Last Close Price 0,47 $
Average target price 1,33 $
Spread / Average Target 187%
EPS Revisions
Managers and Directors
Blaise A Coleman President, Chief Executive Officer & Director
Mark Bradley Chief Financial Officer & Executive Vice President
Mark G. Barberio Chairman
Ruth Thorpe Chief Information Officer
James Patrick Tursi Executive VP-Global Research & Development
Sector and Competitors
1st jan.Capi. (M$)
ENDO INTERNATIONAL PLC-87.63%109
SUN PHARMACEUTICAL INDUSTRIES LTD.4.60%27 394
OTSUKA HOLDINGS CO., LTD.7.58%19 102
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.-9.26%15 379
ONO PHARMACEUTICAL CO., LTD.21.60%13 315
CIPLA LIMITED-0.65%9 768